Rehabilitation of Critically Ill Patients With SARS-CoV-2 Variants in ICU With Limited Resources

NCT ID: NCT05450120

Last Updated: 2022-08-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

UNKNOWN

Clinical Phase

NA

Total Enrollment

88 participants

Study Classification

INTERVENTIONAL

Study Start Date

2020-05-01

Study Completion Date

2022-12-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Acute rehabilitation in critically ill patients can improve post-intensive care unit (post-ICU) physical function. Scientific evidence has considered neuromuscular electrical stimulation (NMES) as a promising approach for the early rehabilitation of patients during and/or after ICU.

Neuromuscular electrostimulation can be an alternative form of muscle exercise that helps to gain strength in critically ill patients with COVID -19, due to the severe weakness that patients experience due to longer MV, analgesia and NMB duration. Thus, the general objective of evaluating the effects of an early rehabilitation protocol on the strength and functionality of patients affected by SARS-CoV-2 variants and specifically compare the effectiveness of NMES associated with the functional rehabilitation protocol(FR). Also, describe demographics, clinical status, ICU therapies, mortality estimates and Hospital outcomes, of every patients admitted in ICU during the observation periods.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Patients in both groups received the functional rehabilitation protocol adapted from the precoce mobilization protocol of Morris et al, 2008. The protocol was defined in 5 stages, with a period between the application of the stages according to the clinical conditions of the patient, in an interval maximum of 24 hours from the beginning of the application of the first stage. The steps included active assisted mobilization exercises, active with Proprioceptive Neuromuscular Facilitation (PNF) method diagonals for upper limbs and bridge exercises, bedside sitting, balance reactions, weight bearing, transfer to an armchair, passive and active orthostatism, static gait and ambulation. The experimental group also received a protocol of neuromuscular electrical stimulation (NMES), applied bilaterally for 30 minutes, using an electrical stimulator with rectangular pulse waves, symmetrical biphasic, applied to the quadriceps femoris and tibialis anterior muscle at the best motor point, activating fast fibers with a pulse time of less than 300 ms and slow pulses with a pulse time of more than 300 ms, with intensity adjusted to obtain visible muscle contraction and/or according to the patient's tolerance.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

COVID-19 Acute Respiratory Distress Syndrome

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

TREATMENT

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Functional Rehabilitation

Functional rehabilitation protocol

Group Type ACTIVE_COMPARATOR

Functional Rehabilitation

Intervention Type OTHER

Functional rehabilitation protocol

NMES + Functional Rehabilitation

Functional rehabilitation protocol associated with neuromuscular electrical stimulation

Group Type EXPERIMENTAL

Functional Rehabilitation

Intervention Type OTHER

Functional rehabilitation protocol

Neuromuscular Electrical Stimulation

Intervention Type OTHER

Neuromuscular electrical stimulation protocol

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Functional Rehabilitation

Functional rehabilitation protocol

Intervention Type OTHER

Neuromuscular Electrical Stimulation

Neuromuscular electrical stimulation protocol

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

Subjects admitted in ICU for \>72hs, undergoing orotracheal intubation and on mechanical ventilation for \>48hs, with a diagnosis of Acute Respiratory Distress Syndrome (ARDS) according to Berlin definition secondary to COVID-19, with shock or organ failure, according to the Diagnosis and Treatment Protocol for Novel Coronavirus Pneumonia (7th Interim Edition) Guideline, and clinical stability:

* mean arterial pressure \< 60 mmHg;
* heart rate \>60 and \<120 beats/minute;
* respiratory rate \<30 breaths/minute;
* oxygen saturation ≥ 92%;
* fraction of inspired oxygen (FiO2) ≤0.6;
* absence of vasopressor dose increase
* absence of dysrhythmia (except for chronic atrial fibrillation);
* controlled sepsis;
* hemoglobin (Hb) \> 8g m/d, plaquettes \>20.000, Glucemia \>70 e \<180;
* without NMBs

Exclusion Criteria

* Patients with movement resistance
* Walking without assistance before the ICU (except using a cane)
* Cognitive impairment before acute illness
* Signs of intracranial hypertension, neuromuscular disease (myasthenia gravis, amyotrophic lateral sclerosis, Guillain-Barré) and stroke; hip fracture, unstable cervical spine, or pathological fracture
* Prior hospitalization (30 days before ICU)
* Readmission to the ICU, within the current hospitalization
* Presence of an implanted cardiac pacemaker or defibrillator, pregnancy, acute myocardial infarction and, for the experimental group (EG), against indications for NMES (deep vein thrombosis, skin lesions, rhabdomyolysis).
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Universidade Federal de Sao Carlos

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Jacqueline R F Vianna

PhD in physical therapy, postdoctoral student Department of Physical Therapy

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Jacqueline Vianna, Phd

Role: PRINCIPAL_INVESTIGATOR

UFSCAR

Jamami, Phd

Role: STUDY_DIRECTOR

UFSCAR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Santa Casa de Batatais

Batatais, São Paulo, Brazil

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Brazil

References

Explore related publications, articles, or registry entries linked to this study.

Dhand UK. Clinical approach to the weak patient in the intensive care unit. Respir Care. 2006 Sep;51(9):1024-40; discussion 1040-1.

Reference Type BACKGROUND
PMID: 16934166 (View on PubMed)

Latronico N, Peli E, Botteri M. Critical illness myopathy and neuropathy. Curr Opin Crit Care. 2005 Apr;11(2):126-32. doi: 10.1097/01.ccx.0000155357.24360.89.

Reference Type BACKGROUND
PMID: 15758592 (View on PubMed)

Herridge MS, Cheung AM, Tansey CM, Matte-Martyn A, Diaz-Granados N, Al-Saidi F, Cooper AB, Guest CB, Mazer CD, Mehta S, Stewart TE, Barr A, Cook D, Slutsky AS; Canadian Critical Care Trials Group. One-year outcomes in survivors of the acute respiratory distress syndrome. N Engl J Med. 2003 Feb 20;348(8):683-93. doi: 10.1056/NEJMoa022450.

Reference Type BACKGROUND
PMID: 12594312 (View on PubMed)

Herridge MS. Legacy of intensive care unit-acquired weakness. Crit Care Med. 2009 Oct;37(10 Suppl):S457-61. doi: 10.1097/CCM.0b013e3181b6f35c.

Reference Type BACKGROUND
PMID: 20046135 (View on PubMed)

De Jonghe B, Sharshar T, Hopkinson N, Outin H. Paresis following mechanical ventilation. Curr Opin Crit Care. 2004 Feb;10(1):47-52. doi: 10.1097/00075198-200402000-00008.

Reference Type BACKGROUND
PMID: 15166849 (View on PubMed)

Ali NA, O'Brien JM Jr, Hoffmann SP, Phillips G, Garland A, Finley JC, Almoosa K, Hejal R, Wolf KM, Lemeshow S, Connors AF Jr, Marsh CB; Midwest Critical Care Consortium. Acquired weakness, handgrip strength, and mortality in critically ill patients. Am J Respir Crit Care Med. 2008 Aug 1;178(3):261-8. doi: 10.1164/rccm.200712-1829OC. Epub 2008 May 29.

Reference Type BACKGROUND
PMID: 18511703 (View on PubMed)

Latronico N, Bolton CF. Critical illness polyneuropathy and myopathy: a major cause of muscle weakness and paralysis. Lancet Neurol. 2011 Oct;10(10):931-41. doi: 10.1016/S1474-4422(11)70178-8.

Reference Type BACKGROUND
PMID: 21939902 (View on PubMed)

Latronico N. Critical illness polyneuropathy and myopathy 20 years later. No man's land? No, it is our land! Intensive Care Med. 2016 Nov;42(11):1790-1793. doi: 10.1007/s00134-016-4475-4. Epub 2016 Aug 8. No abstract available.

Reference Type BACKGROUND
PMID: 27502507 (View on PubMed)

Bolton CF, Gilbert JJ, Hahn AF, Sibbald WJ. Polyneuropathy in critically ill patients. J Neurol Neurosurg Psychiatry. 1984 Nov;47(11):1223-31. doi: 10.1136/jnnp.47.11.1223.

Reference Type BACKGROUND
PMID: 6094735 (View on PubMed)

Bonorino KC, Cani KC. Early mobilization in the time of COVID-19. Rev Bras Ter Intensiva. 2020 Oct-Dec;32(4):484-486. doi: 10.5935/0103-507X.20200086. No abstract available.

Reference Type BACKGROUND
PMID: 33470350 (View on PubMed)

Hodgson C, Needham D, Haines K, Bailey M, Ward A, Harrold M, Young P, Zanni J, Buhr H, Higgins A, Presneill J, Berney S. Feasibility and inter-rater reliability of the ICU Mobility Scale. Heart Lung. 2014 Jan-Feb;43(1):19-24. doi: 10.1016/j.hrtlng.2013.11.003. Epub 2013 Nov 19.

Reference Type BACKGROUND
PMID: 24373338 (View on PubMed)

Zanni JM, Korupolu R, Fan E, Pradhan P, Janjua K, Palmer JB, Brower RG, Needham DM. Rehabilitation therapy and outcomes in acute respiratory failure: an observational pilot project. J Crit Care. 2010 Jun;25(2):254-62. doi: 10.1016/j.jcrc.2009.10.010. Epub 2009 Nov 26.

Reference Type BACKGROUND
PMID: 19942399 (View on PubMed)

Bailey PP, Miller RR 3rd, Clemmer TP. Culture of early mobility in mechanically ventilated patients. Crit Care Med. 2009 Oct;37(10 Suppl):S429-35. doi: 10.1097/CCM.0b013e3181b6e227.

Reference Type BACKGROUND
PMID: 20046131 (View on PubMed)

Thomas P, Baldwin C, Bissett B, Boden I, Gosselink R, Granger CL, Hodgson C, Jones AY, Kho ME, Moses R, Ntoumenopoulos G, Parry SM, Patman S, van der Lee L. Physiotherapy management for COVID-19 in the acute hospital setting: clinical practice recommendations. J Physiother. 2020 Apr;66(2):73-82. doi: 10.1016/j.jphys.2020.03.011. Epub 2020 Mar 30.

Reference Type BACKGROUND
PMID: 32312646 (View on PubMed)

Stiller K. Physiotherapy in intensive care: towards an evidence-based practice. Chest. 2000 Dec;118(6):1801-13. doi: 10.1378/chest.118.6.1801. No abstract available.

Reference Type BACKGROUND
PMID: 11115476 (View on PubMed)

Maffiuletti NA, Gondin J, Place N, Stevens-Lapsley J, Vivodtzev I, Minetto MA. Clinical Use of Neuromuscular Electrical Stimulation for Neuromuscular Rehabilitation: What Are We Overlooking? Arch Phys Med Rehabil. 2018 Apr;99(4):806-812. doi: 10.1016/j.apmr.2017.10.028. Epub 2017 Dec 9.

Reference Type BACKGROUND
PMID: 29233625 (View on PubMed)

De Jonghe, B., Sharshar, T., Lefaucheur, J.-P., & Outin, H. Critical Illness Neuromyopathy. Clinical Pulmonary Medicine. 2005; 12(2): 90-96.

Reference Type BACKGROUND

Coronaviridae Study Group of the International Committee on Taxonomy of Viruses. The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2. Nat Microbiol. 2020 Apr;5(4):536-544. doi: 10.1038/s41564-020-0695-z. Epub 2020 Mar 2.

Reference Type BACKGROUND
PMID: 32123347 (View on PubMed)

De Jonghe B, Sharshar T, Lefaucheur JP, Authier FJ, Durand-Zaleski I, Boussarsar M, Cerf C, Renaud E, Mesrati F, Carlet J, Raphael JC, Outin H, Bastuji-Garin S; Groupe de Reflexion et d'Etude des Neuromyopathies en Reanimation. Paresis acquired in the intensive care unit: a prospective multicenter study. JAMA. 2002 Dec 11;288(22):2859-67. doi: 10.1001/jama.288.22.2859.

Reference Type RESULT
PMID: 12472328 (View on PubMed)

Morris PE, Goad A, Thompson C, Taylor K, Harry B, Passmore L, Ross A, Anderson L, Baker S, Sanchez M, Penley L, Howard A, Dixon L, Leach S, Small R, Hite RD, Haponik E. Early intensive care unit mobility therapy in the treatment of acute respiratory failure. Crit Care Med. 2008 Aug;36(8):2238-43. doi: 10.1097/CCM.0b013e318180b90e.

Reference Type RESULT
PMID: 18596631 (View on PubMed)

Needham DM. Mobilizing patients in the intensive care unit: improving neuromuscular weakness and physical function. JAMA. 2008 Oct 8;300(14):1685-90. doi: 10.1001/jama.300.14.1685.

Reference Type RESULT
PMID: 18840842 (View on PubMed)

Gosselink R, Bott J, Johnson M, Dean E, Nava S, Norrenberg M, Schonhofer B, Stiller K, van de Leur H, Vincent JL. Physiotherapy for adult patients with critical illness: recommendations of the European Respiratory Society and European Society of Intensive Care Medicine Task Force on Physiotherapy for Critically Ill Patients. Intensive Care Med. 2008 Jul;34(7):1188-99. doi: 10.1007/s00134-008-1026-7. Epub 2008 Feb 19.

Reference Type RESULT
PMID: 18283429 (View on PubMed)

Bourdin G, Barbier J, Burle JF, Durante G, Passant S, Vincent B, Badet M, Bayle F, Richard JC, Guerin C. The feasibility of early physical activity in intensive care unit patients: a prospective observational one-center study. Respir Care. 2010 Apr;55(4):400-7.

Reference Type RESULT
PMID: 20406506 (View on PubMed)

Maffiuletti NA, Roig M, Karatzanos E, Nanas S. Neuromuscular electrical stimulation for preventing skeletal-muscle weakness and wasting in critically ill patients: a systematic review. BMC Med. 2013 May 23;11:137. doi: 10.1186/1741-7015-11-137.

Reference Type RESULT
PMID: 23701811 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

07351119.2.0000.5381

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.